Sanofi relocated 2,000 employees to a new $130M Morristown flagship office at M Station West in May, leaving Bridgewater.

Sanofi is acquiring Vigil Neuroscience, a biotech firm focused on novel neurodegenerative disease therapies, to boost its ...

Global healthcare company Sanofi yesterday formally opened its new flagship US offices at M Station West in Morristown.

The approval tees GSK up to challenge Sanofi and Regeneron, which in September 2024 won the first biologic approval for COPD ...

Sanofi spent $130 million outfitting the 260,000 square feet it now occupies for 2,000 employees at M Station West.

Novo Nordisk NVO announced the surprise resignation of its chief executive officer (CEO), Lars Fruergaard Jørgensen. Sanofi ...

Due to self-administration & preventive use of probiotics, besides doctors’ prescriptions, probiotic brands Enterogermina & ...

Sanofi to acquire clinical-stage biotechnology company, Vigil Neuroscience for $470 million: Paris Friday, May 23, 2025, 11:00 Hrs [IST] Sanofi, an innovative global healthcare co ...

GSK Plc won US approval for its drug to treat a deadly lung disease, ramping up competition with rival Sanofi.

Deal includes VG-3927, a first-in-class TREM2 agonist aimed at advancing next-generation Alzheimer disease therapies.

SANOFI will acquire Vigil Neuroscience, a clinical-stage biotech company in a $470-million deal, the companies said on Thursday, as the French drugmaker seeks to boost its neurological pipeline ...

From my colleague Adam Feuerstein: French drug maker Sanofi is acquiring the small biotech Vigil Neuroscience for $470 ...